121 related articles for article (PubMed ID: 18829545)
1. Dual roles for coactivator activator and its counterbalancing isoform coactivator modulator in human kidney cell tumorigenesis.
Kang YK; Schiff R; Ko L; Wang T; Tsai SY; Tsai MJ; O'Malley BW
Cancer Res; 2008 Oct; 68(19):7887-96. PubMed ID: 18829545
[TBL] [Abstract][Full Text] [Related]
2. Identification and characterization of RRM-containing coactivator activator (CoAA) as TRBP-interacting protein, and its splice variant as a coactivator modulator (CoAM).
Iwasaki T; Chin WW; Ko L
J Biol Chem; 2001 Sep; 276(36):33375-83. PubMed ID: 11443112
[TBL] [Abstract][Full Text] [Related]
3. Switched alternative splicing of oncogene CoAA during embryonal carcinoma stem cell differentiation.
Yang Z; Sui Y; Xiong S; Liour SS; Phillips AC; Ko L
Nucleic Acids Res; 2007; 35(6):1919-32. PubMed ID: 17337438
[TBL] [Abstract][Full Text] [Related]
4. E2/Estrogen receptor/sjogren syndrome-associated autoantigen relieves coactivator activator-induced G1/S arrest to promote breast tumorigenicity.
Kang YK; Jung SY; Qin J; Li C; Tsai SY; Tsai MJ; O'Malley BW
Mol Cell Biol; 2014 May; 34(9):1670-81. PubMed ID: 24567374
[TBL] [Abstract][Full Text] [Related]
5. Synovial sarcoma translocation (SYT) encodes a nuclear receptor coactivator.
Iwasaki T; Koibuchi N; Chin WW
Endocrinology; 2005 Sep; 146(9):3892-9. PubMed ID: 15919756
[TBL] [Abstract][Full Text] [Related]
6. Hsa-let-7a functions as a tumor suppressor in renal cell carcinoma cell lines by targeting c-myc.
Liu Y; Yin B; Zhang C; Zhou L; Fan J
Biochem Biophys Res Commun; 2012 Jan; 417(1):371-5. PubMed ID: 22155254
[TBL] [Abstract][Full Text] [Related]
7. Wnt antagonist DICKKOPF-3 (Dkk-3) induces apoptosis in human renal cell carcinoma.
Ueno K; Hirata H; Majid S; Chen Y; Zaman MS; Tabatabai ZL; Hinoda Y; Dahiya R
Mol Carcinog; 2011 Jun; 50(6):449-57. PubMed ID: 21268126
[TBL] [Abstract][Full Text] [Related]
8. Wnt antagonist DKK1 acts as a tumor suppressor gene that induces apoptosis and inhibits proliferation in human renal cell carcinoma.
Hirata H; Hinoda Y; Nakajima K; Kawamoto K; Kikuno N; Ueno K; Yamamura S; Zaman MS; Khatri G; Chen Y; Saini S; Majid S; Deng G; Ishii N; Dahiya R
Int J Cancer; 2011 Apr; 128(8):1793-803. PubMed ID: 20549706
[TBL] [Abstract][Full Text] [Related]
9. [Effects of SIPL1 screened by suppression subtractive hybridization (SSH) on biological function and drug resistance of renal cell carcinoma cells].
Li CY; Yao AM; Chang XN; Guo YH; Xu R
Zhonghua Zhong Liu Za Zhi; 2013 Dec; 35(12):897-903. PubMed ID: 24506958
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-34a suppresses malignant transformation by targeting c-Myc transcriptional complexes in human renal cell carcinoma.
Yamamura S; Saini S; Majid S; Hirata H; Ueno K; Chang I; Tanaka Y; Gupta A; Dahiya R
Carcinogenesis; 2012 Feb; 33(2):294-300. PubMed ID: 22159222
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of DLC-1 induces cell apoptosis and proliferation inhibition in the renal cell carcinoma.
Zhang T; Zheng J; Jiang N; Wang G; Shi Q; Liu C; Lu Y
Cancer Lett; 2009 Sep; 283(1):59-67. PubMed ID: 19380190
[TBL] [Abstract][Full Text] [Related]
12. Gene amplification and associated loss of 5' regulatory sequences of CoAA in human cancers.
Sui Y; Yang Z; Xiong S; Zhang L; Blanchard KL; Peiper SC; Dynan WS; Tuan D; Ko L
Oncogene; 2007 Feb; 26(6):822-35. PubMed ID: 16878147
[TBL] [Abstract][Full Text] [Related]
13. miR-141 is a key regulator of renal cell carcinoma proliferation and metastasis by controlling EphA2 expression.
Chen X; Wang X; Ruan A; Han W; Zhao Y; Lu X; Xiao P; Shi H; Wang R; Chen L; Chen S; Du Q; Yang H; Zhang X
Clin Cancer Res; 2014 May; 20(10):2617-30. PubMed ID: 24647573
[TBL] [Abstract][Full Text] [Related]
14. Overexpression and amplification of c-myc in the Syrian hamster kidney during estrogen carcinogenesis: a probable critical role in neoplastic transformation.
Li JJ; Hou X; Banerjee SK; Liao DZ; Maggouta F; Norris JS; Li SA
Cancer Res; 1999 May; 59(10):2340-6. PubMed ID: 10344741
[TBL] [Abstract][Full Text] [Related]
15. ERK-dependent downregulation of Skp2 reduces Myc activity with HGF, leading to inhibition of cell proliferation through a decrease in Id1 expression.
Li X; Bian Y; Takizawa Y; Hashimoto T; Ikoma T; Tanaka J; Kitamura N; Inagaki Y; Komada M; Tanaka T
Mol Cancer Res; 2013 Nov; 11(11):1437-47. PubMed ID: 24177224
[TBL] [Abstract][Full Text] [Related]
16. Anti-CD26 monoclonal antibody-mediated G1-S arrest of human renal clear cell carcinoma Caki-2 is associated with retinoblastoma substrate dephosphorylation, cyclin-dependent kinase 2 reduction, p27(kip1) enhancement, and disruption of binding to the extracellular matrix.
Inamoto T; Yamochi T; Ohnuma K; Iwata S; Kina S; Inamoto S; Tachibana M; Katsuoka Y; Dang NH; Morimoto C
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3470-7. PubMed ID: 16740772
[TBL] [Abstract][Full Text] [Related]
17. Functional pre- mRNA trans-splicing of coactivator CoAA and corepressor RBM4 during stem/progenitor cell differentiation.
Brooks YS; Wang G; Yang Z; Smith KK; Bieberich E; Ko L
J Biol Chem; 2009 Jul; 284(27):18033-46. PubMed ID: 19416963
[TBL] [Abstract][Full Text] [Related]
18. STAT1 represses Skp2 gene transcription to promote p27Kip1 stabilization in Ras-transformed cells.
Wang S; Raven JF; Koromilas AE
Mol Cancer Res; 2010 May; 8(5):798-805. PubMed ID: 20407011
[TBL] [Abstract][Full Text] [Related]
19. RB1CC1 functions as a tumor-suppressing gene in renal cell carcinoma via suppression of PYK2 activity and disruption of TAZ-mediated PDL1 transcription activation.
Chen P; Duan Y; Lu X; Chen L; Zhang W; Wang H; Hu R; Liu S
Cancer Immunol Immunother; 2021 Nov; 70(11):3261-3275. PubMed ID: 33837850
[TBL] [Abstract][Full Text] [Related]
20. CoAA, a nuclear receptor coactivator protein at the interface of transcriptional coactivation and RNA splicing.
Auboeuf D; Dowhan DH; Li X; Larkin K; Ko L; Berget SM; O'Malley BW
Mol Cell Biol; 2004 Jan; 24(1):442-53. PubMed ID: 14673176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
